With all eyes on AI-protein design, Nabla says it can model therapeutic antibodies
Announcing JAM-2: Drug-like antibodies straight from the computer
Technical ReportAnnouncing JAM-2: Drug-like antibodies straight from the computer
Technical ReportWith all eyes on AI-protein design, Nabla says it can model therapeutic antibodies